Theratechnologies to Announce Second Quarter 2025 Financial Results
Theratechnologies (NASDAQ: THTX), a commercial-stage biopharmaceutical company, will release its second quarter 2025 financial results on Wednesday, July 9, 2025. The results will cover the period ended May 31, 2025. Due to a recently announced acquisition of the Company on July 2, 2025, management will not host a conference call to discuss the results.
Theratechnologies (NASDAQ: THTX), un'azienda biofarmaceutica in fase commerciale, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 mercoledì 9 luglio 2025. I risultati riguarderanno il periodo terminato il 31 maggio 2025. A causa di un'acquisizione recentemente annunciata della Società il 2 luglio 2025, la direzione non terrà una conference call per discutere i risultati.
Theratechnologies (NASDAQ: THTX), una empresa biofarmacéutica en etapa comercial, publicará sus resultados financieros del segundo trimestre de 2025 el miércoles 9 de julio de 2025. Los resultados cubrirán el período finalizado el 31 de mayo de 2025. Debido a una adquisición anunciada recientemente de la Compañía el 2 de julio de 2025, la dirección no realizará una llamada conferencia para discutir los resultados.
Theratechnologies (NASDAQ: THTX)는 상업 단계의 생명공학 제약 회사로, 2025년 2분기 재무 결과를 2025년 7월 9일 수요일에 발표할 예정입니다. 결과는 2025년 5월 31일 종료된 기간을 포함합니다. 2025년 7월 2일 회사의 최근 인수 발표로 인해 경영진은 결과에 대해 논의하는 컨퍼런스 콜을 진행하지 않을 것입니다.
Theratechnologies (NASDAQ: THTX), une société biopharmaceutique en phase commerciale, publiera ses résultats financiers du deuxième trimestre 2025 le mercredi 9 juillet 2025. Les résultats couvriront la période se terminant le 31 mai 2025. En raison d'une acquisition récemment annoncée de la Société le 2 juillet 2025, la direction ne tiendra pas de conférence téléphonique pour discuter des résultats.
Theratechnologies (NASDAQ: THTX), ein biopharmazeutisches Unternehmen in der kommerziellen Phase, wird seine Finanzergebnisse für das zweite Quartal 2025 am Mittwoch, den 9. Juli 2025, veröffentlichen. Die Ergebnisse beziehen sich auf den Zeitraum bis zum 31. Mai 2025. Aufgrund einer kürzlich am 2. Juli 2025 angekündigten Übernahme des Unternehmens wird das Management keine Telefonkonferenz zur Besprechung der Ergebnisse abhalten.
- None.
- None.
MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.
Given the announcement of July 2, 2025, concerning the acquisition of the Company, a conference call will not be held.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X.
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) release Q2 2025 earnings?
Why isn't Theratechnologies (THTX) holding a Q2 2025 earnings call?
What period does Theratechnologies' Q2 2025 earnings cover?
What was announced about Theratechnologies' acquisition?
